P3 Health Partners Inc. (PIII)
NASDAQ: PIII · Real-Time Price · USD
8.00
-0.19 (-2.32%)
At close: May 14, 2025, 4:00 PM
8.18
+0.18 (2.25%)
After-hours: May 14, 2025, 4:05 PM EDT
P3 Health Partners Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for P3 Health Partners stock ranges from a low of $12.5 to a high of $20. The average analyst price target of $16.25 forecasts a 103.13% increase in the stock price over the next year.
Price Target: $16.25 (+103.13%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for P3 Health Partners stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Maintains $50 → $20 | Strong Buy | Maintains | $50 → $20 | +150.00% | Apr 21, 2025 |
| TD Cowen | TD Cowen | Hold Maintains $45 → $13 | Hold | Maintains | $45 → $13 | +56.25% | Nov 20, 2024 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 1, 2024 |
| Lake Street | Lake Street | Strong Buy Maintains $450 → $225 | Strong Buy | Maintains | $450 → $225 | +2,712.50% | Mar 14, 2024 |
| BTIG | BTIG | Strong Buy Initiates $250 | Strong Buy | Initiates | $250 | +3,025.00% | Sep 1, 2023 |
Financial Forecast
Revenue This Year
1.44B
from 1.50B
Decreased by -4.30%
Revenue Next Year
1.53B
from 1.44B
Increased by 6.41%
EPS This Year
-24.72
from -54.06
EPS Next Year
-17.00
from -24.72
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.5B | 1.7B | 1.7B |
| Avg | 1.4B | 1.5B | 1.6B |
| Low | 1.4B | 1.4B | 1.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.2% | 16.7% | 8.0% |
| Avg | -4.3% | 6.4% | 4.9% |
| Low | -9.1% | -4.5% | 0.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -15.75 | -7.88 | -9.98 |
| Avg | -24.72 | -17.00 | -9.69 |
| Low | -39.69 | -26.46 | -9.31 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.